Clinical Trial Update: Stereotactic Prostate Adaptive Radiotherapy Utilising Kilovoltage Intrafraction Monitoring [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a stereotactic radiotherapy approach for prostate cancer using kilovoltage intrafraction monitoring.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University of Sydney | Conditions: Prostate Cancer | Phase 2 | Status: UNKNOWN